Thursday, March 10, 2016 11:34:20 AM
http://www.prnewswire.com/news-releases/avant-diagnostics-and-amarantus-diagnostics-to-combine-operations-with-theranostics-health-571258081.html
This AMBS Owned Company = AVDX is Currently Profitable and is already Generating income from several Tests!!
AMBS's science will be used to make More Tests & Testing Kits = So AVDX will generate even More Profits in the Future!
http://content.stockpr.com/amarantus/db/184/1127/pdf/AVDX+post-merger+Presentation+FINAL.pdf
• Combination of 3 companies with synergies in biology and indications
• 2015 Pharma Services revenue of $1.5M expected to grow significant o Theralink® in breast cancer to expand into other indications
o LymPro Test® to add significant potential to pharma services revenue potential o Leader in cell cycle biology
• CLIA laboratory operating to highest standards
• Introducing proprietary diagnostic tests into market in 2017
o Ovarian cancer: OvaDx® Market potential of $2B+ (replacing CA-125)
o Multiple Sclerosis: MSPrecise® Market potential of $200M+ (improving Tx intervention) o Alzheimer’s disease: LymPro Test® Market potential of $3B+ (65yr Medicare screen)
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
